Babak Dehestani

661 total citations
12 papers, 482 citations indexed

About

Babak Dehestani is a scholar working on Physiology, Endocrinology, Diabetes and Metabolism and Epidemiology. According to data from OpenAlex, Babak Dehestani has authored 12 papers receiving a total of 482 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Physiology, 4 papers in Endocrinology, Diabetes and Metabolism and 3 papers in Epidemiology. Recurrent topics in Babak Dehestani's work include Diabetes Treatment and Management (3 papers), Nutrition and Health in Aging (3 papers) and Diet and metabolism studies (3 papers). Babak Dehestani is often cited by papers focused on Diabetes Treatment and Management (3 papers), Nutrition and Health in Aging (3 papers) and Diet and metabolism studies (3 papers). Babak Dehestani collaborates with scholars based in Ireland, Iran and United States. Babak Dehestani's co-authors include Carel W. le Roux, Mohamed A. Zayed, Andrea Ballabio, Jan R. Crowley, Daping Fan, Ali Javaheri, Somashubhra Bhattacharya, Joel D. Schilling, Conrad C. Weihl and Eric Song and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Arteriosclerosis Thrombosis and Vascular Biology.

In The Last Decade

Babak Dehestani

10 papers receiving 474 citations

Peers

Babak Dehestani

EPIDE

EDM

PHYSI

IMMUN

Milena Vesković Serbia

Toshihiko Hashinaga Japan

Tomohito Izumi Japan

Dragana Rajcic Austria

Shinjiro Kodama Japan

Valentina Ceccarelli Italy

Mizuki Endo Japan

Xinyang Yu China

Eiji Takeda Japan

Flavien Berthou Switzerland

Milena Vesković Serbia

Babak Dehestani

162 ×0.7

EPIDE

93 ×0.7

93 ×0.9

EDM

63 ×0.7

PHYSI

23 ×0.3

IMMUN

Citations per year, relative to Babak Dehestani Babak Dehestani (= 1×) peers Milena Vesković

Countries citing papers authored by Babak Dehestani

Since Specialization

Citations

This map shows the geographic impact of Babak Dehestani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Babak Dehestani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Babak Dehestani more than expected).

Fields of papers citing papers by Babak Dehestani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Babak Dehestani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Babak Dehestani. The network helps show where Babak Dehestani may publish in the future.

Co-authorship network of co-authors of Babak Dehestani

This figure shows the co-authorship network connecting the top 25 collaborators of Babak Dehestani. A scholar is included among the top collaborators of Babak Dehestani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Babak Dehestani. Babak Dehestani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Al‐Najim, Werd, Babak Dehestani, Danielle H. Bodicoat, et al.. (2025). Outcomes of Different Lifestyle Approaches in a Multicentre, Open-Label, Parallel-Group, Randomised Controlled Trial of the Effectiveness of Integrating a Pragmatic Pathway for Prescribing Liraglutide 3.0 mg in Weight Management Services (STRIVE Study). Metabolites. 15(6). 398–398.

Martin, William P., et al.. (2021). Liraglutide Does Not Adversely Impact Fat‐Free Mass Loss. Obesity. 29(3). 529–534. 17 indexed citations

Dehestani, Babak, et al.. (2021). Clinical Impact of Liraglutide as a Treatment of Obesity. Clinical Pharmacology Advances and Applications. Volume 13. 53–60. 41 indexed citations

Dehestani, Babak, et al.. (2021). Amylin as a Future Obesity Treatment. Journal of Obesity & Metabolic Syndrome. 30(4). 320–325. 40 indexed citations

Yousefshahi, Fardin, et al.. (2019). Prevalence and Risk Factors of Hypoxemia after Coronary Artery Bypass Grafting: The Time to Change Our Conceptions. SHILAP Revista de lepidopterología. 14(2). 74–80. 4 indexed citations

Dehestani, Babak & Carel W. le Roux. (2019). The Role of the Small Bowel in Unintentional Weight Loss after Treatment of Upper Gastrointestinal Cancers. Journal of Clinical Medicine. 8(7). 942–942. 2 indexed citations

Sergin, Ismail, Trent D. Evans, Xiangyu Zhang, et al.. (2017). Exploiting macrophage autophagy-lysosomal biogenesis as a therapy for atherosclerosis. Nature Communications. 8(1). 15750–15750. 271 indexed citations

Yaghmaei, Parichehreh, Babak Dehestani, Samira Ghorbani, Farzaneh Abbasi, & Azadeh Ebrahim‐Habibi. (2017). Indole-based derivatives effect on rats with polycystic ovary syndrome. Journal of Pharmaceutical Investigation. 47(5). 439–444.

Motamed, Nima, Behnam Rabiee, Hossein Poustchi, et al.. (2016). Non-alcoholic fatty liver disease (NAFLD) and 10-year risk of cardiovascular diseases. Clinics and Research in Hepatology and Gastroenterology. 41(1). 31–38. 75 indexed citations

10.

Sergin, Ismail, Somashubhra Bhattacharya, Xiangyu Zhang, et al.. (2016). Abstract 4: Enhancing the Ability of Macrophages to Orchestrate Selective Autophagy and Lysosomal Biogenesis Protects Against Atherosclerosis. Arteriosclerosis Thrombosis and Vascular Biology. 36(suppl_1). 1 indexed citations

11.

Keshteli, Ammar Hassanzadeh, Babak Dehestani, Hamed Daghaghzadeh, & Peyman Adibi. (2015). Epidemiological features of irritable bowel syndrome and its subtypes among Iranian adults.. PubMed. 28(2). 253–258. 28 indexed citations

12.

Dehestani, Babak, et al.. (2014). Thioflavin T effect in diabetic Wistar rats: Reporting the antihyperglycemic property of an amyloid probing dye. Pharmacological Reports. 67(2). 364–369. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact